Skip to content
Movie Casting Call
Author:
Bridge to Life, Ltd.
Landmark Study Published in the Journal of the American Medical Association (JAMA) Surgery Validates Bridge to Life’s VitaSmart™ HOPE Perfusion System as a Superior Organ Preservation Technology
May 28, 2026
Groundbreaking Global Study Establishes First International Benchmark Framework for Pediatric Liver Transplantation
May 11, 2026
Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment
May 11, 2026
Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026
April 28, 2026
New Data Demonstrate Safety and Effectiveness of Bridge to Life’s VitaSmart Hypothermic Oxygenated Machine Perfusion (HOPE) System in Partial Graft Pediatric Liver Transplantation
April 24, 2026
Bridge to Life Announces First Commercial Use of VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System by Major U.S. Transplant Center Following FDA Clearance, Signaling Early Physician Confidence
March 24, 2026